Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapeutic effects of IL-7 during a chronic viral infection in mice
Som G. Nanjappa, Eui Ho Kim, M. Suresh
Blood (2011) Vol. 117, Iss. 19, pp. 5123-5132
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Molecular and cellular insights into T cell exhaustion
E. John Wherry, Makoto Kurachi
Nature reviews. Immunology (2015) Vol. 15, Iss. 8, pp. 486-499
Open Access | Times Cited: 3709
T cell exhaustion
E. John Wherry
Nature Immunology (2011) Vol. 12, Iss. 6, pp. 492-499
Closed Access | Times Cited: 3488
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken, Morgan A. Sammons, Pamela M. Odorizzi, et al.
Science (2016) Vol. 354, Iss. 6316, pp. 1160-1165
Open Access | Times Cited: 1113
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 653
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Masao Hashimoto, Alice O. Kamphorst, Se Jin Im, et al.
Annual Review of Medicine (2018) Vol. 69, Iss. 1, pp. 301-318
Open Access | Times Cited: 534
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall, Terry J. Fry, Ronald E. Gress
Nature reviews. Immunology (2011) Vol. 11, Iss. 5, pp. 330-342
Open Access | Times Cited: 518
T cell exhaustion during persistent viral infections
Shannon M. Kahan, E. John Wherry, Allan Zajac
Virology (2015) Vol. 479-480, pp. 180-193
Open Access | Times Cited: 275
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
Erin E. West, Hyun Tak Jin, Ata Ur Rasheed, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 6, pp. 2604-2615
Open Access | Times Cited: 269
T‐cell responses and therapies against SARS‐CoV‐2 infection
Salman M. Toor, Reem Saleh, Varun Sasidharan Nair, et al.
Immunology (2020) Vol. 162, Iss. 1, pp. 30-43
Open Access | Times Cited: 198
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 158
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis
Michael P. Pender
Autoimmune Diseases (2012) Vol. 2012, pp. 1-16
Open Access | Times Cited: 180
Anti-viral CD8 T cells and the cytokines that they love
Maureen A. Cox, Shannon M. Kahan, Allan Zajac
Virology (2012) Vol. 435, Iss. 1, pp. 157-169
Open Access | Times Cited: 139
Innate and Adaptive Immune Regulation During Chronic Viral Infections
Elina I. Zúñiga, Mónica Macal, Gavin Lewis, et al.
Annual Review of Virology (2015) Vol. 2, Iss. 1, pp. 573-597
Open Access | Times Cited: 127
Role of Lymphocytic Choriomeningitis Virus (LCMV) in Understanding Viral Immunology: Past, Present and Future
Xin Zhou, Srividya Ramachandran, Margaret Mann, et al.
Viruses (2012) Vol. 4, Iss. 11, pp. 2650-2669
Open Access | Times Cited: 124
IL-2 and Beyond in Cancer Immunotherapy
John Wrangle, Alicia Patterson, Christopher Johnson, et al.
Journal of Interferon & Cytokine Research (2018) Vol. 38, Iss. 2, pp. 45-68
Open Access | Times Cited: 109
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 34
Antigen-Independent Induction of Tim-3 Expression on Human T Cells by the Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Is Associated with Proliferation and Is Dependent on the Phosphoinositide 3-Kinase Pathway
Shariq Mujib, R. Brad Jones, Calvin Lo, et al.
The Journal of Immunology (2012) Vol. 188, Iss. 8, pp. 3745-3756
Open Access | Times Cited: 87
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
Robert C. Axtell, Chander Raman, Lawrence Steinman
Clinical Reviews in Allergy & Immunology (2012) Vol. 44, Iss. 2, pp. 114-120
Open Access | Times Cited: 86
Networking at the Level of Host Immunity: Immune Cell Interactions during Persistent Viral Infections
Cherie Ng, Laura M. Snell, David G. Brooks, et al.
Cell Host & Microbe (2013) Vol. 13, Iss. 6, pp. 652-664
Open Access | Times Cited: 84
Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia
Yuichiro Shindo, Anja Fuchs, Christopher G. Davis, et al.
Journal of Leukocyte Biology (2016) Vol. 101, Iss. 2, pp. 543-554
Open Access | Times Cited: 76
Harnessing the Power of IL-7 to Boost T Cell Immunity in Experimental and Clinical Immunotherapies
Jung‐Hyun Park, Seung‐Woo Lee, Donghoon Choi, et al.
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral Infection
Masao Hashimoto, Se Jin Im, Koichi Araki, et al.
Cold Spring Harbor Perspectives in Biology (2017) Vol. 11, Iss. 1, pp. a028464-a028464
Open Access | Times Cited: 58
Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China
Mei Zhou, Zhengrong Yin, Juanjuan Xu, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 9, pp. 1473-1488
Open Access | Times Cited: 37
Unravelling the modified T cell receptor through Gen-Next CAR T cell therapy in Glioblastoma: Current status and future challenges
Bhavya Bhutani, Vinay Sharma, Nirmal Kumar Ganguly, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117987-117987
Closed Access
Page 1 - Next Page

Scroll to top